in ,

JLABS @ Washington DC Seeks Innovations for Pediatric Influenza Interventions

Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies.

In addition to welcoming the awardees in this QuickFire Challenge upon opening in 2020, JLABS @ Washington, DC offers residency to pharmaceutical, medical device, consumer and health technology companies that are aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies.

Applications in the following focus areas are specifically emphasized:

  • Pediatric-focused innovations in influenza
  • Novel solutions for influenza vaccine delivery
  • Influenza pre-exposure including antivirals prophylaxis formulation
  • Innovations in pediatric oncology port technologies
  • Drugs that target pediatric-specific driver genes
  • Bedside, rapid tumor genetic testing
  • Pediatric-specific implants for trauma & fracture care including growth-enabling spine & trauma orthopedic implants
  • Innovative treatment options for adolescent idiopathic scoliosis
  • Surgical robotics to treat pediatric patients

Submissions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

  • Potential impact
  • Uniqueness of solution & level of competition in the current market
  • Quality & feasibility of the technology
  • Team credibility & capabilities
  • Plans for utilizing JLABS @ Washington, DC

The submission deadline is 24 April 2020. Please visit the JLABS website for more information.

Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research Funding

CEPI-EDCTP Seeks Proposals for Lassa Virus Vaccines